Sensei Biotherapeutics Inc (SNSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,100 | -14,969 | -9,602 | -4,692 | -16,740 |
| Depreciation Amortization | 1,787 | 1,717 | 1,653 | 1,601 | 1,467 |
| Other Working Capital | -397 | -2,420 | -1,142 | -2,526 | 3,469 |
| Other Operating Activity | 1,005 | 647 | -136 | -843 | 3,233 |
| Operating Cash Flow | $-17,705 | $-15,025 | $-9,227 | $-6,460 | $-8,571 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,206 | -890 | -54 | -52 | -53 |
| Net Acquisitions | -197 | -197 | -197 | N/A | 0 |
| Investing Cash Flow | $-1,403 | $-1,087 | $-251 | $-52 | $-53 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 567 | 567 | 567 | N/A | N/A |
| Common Stock Issued | 20 | 0 | 0 | 0 | N/A |
| Other Financing Activity | 34,866 | 19,027 | 10,546 | 10,557 | 8,222 |
| Financing Cash Flow | $35,453 | $19,594 | $11,113 | $10,557 | $8,222 |
| Beginning Cash Position | 251 | 251 | 251 | 251 | 653 |
| End Cash Position | 16,596 | 3,733 | 1,886 | 4,296 | 251 |
| Net Cash Flow | $16,345 | $3,482 | $1,635 | $4,045 | $-402 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,705 | -15,025 | -9,227 | -6,460 | -8,571 |
| Capital Expenditure | -1,206 | -890 | -54 | -52 | N/A |
| Free Cash Flow | -18,911 | -15,915 | -9,281 | -6,512 | -8,571 |